Home › Vascular Diseases › North Carolina › Durham
Vascular Diseases clinical trials in Durham, NC
4 studies for Vascular Diseases are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Zenith® Fenestrated+ Clinical Study
Recruiting
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance
RecruitingObservational study
- Duke University, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
Global Paradise System US Post Approval Study
RecruitingObservational study
- Durham VA Health System, Durham
- University of North Carolina at Chapel Hill School of Medicine, Chapel Hill · 10 mi away
SPYRAL GEMINI Pilot Study
Recruiting
- University of North Carolina (UNC) Memorial Hospital, Chapel Hill · 10 mi away
About Vascular Diseases
Your vascular system is made up of blood vessels that carry blood to and from the heart. Learn about vascular diseases and their treatments.
More about Vascular Diseases on MedlinePlus
Vascular Diseases trials in other cities
- Boston, MA13 studies
- Washington, DC7 studies
- New York City, NY5 studies
- Cleveland, OH4 studies
- Atlanta, GA4 studies
- Mountain View, CA4 studies
- Los Angeles, CA4 studies
- Tampa, FL4 studies
- Dallas, TX4 studies
- Detroit, MI4 studies
- St. Louis, MO4 studies
- Sacramento, CA3 studies
Other studies in Durham
- Breast Cancer63 studies
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer39 studies
- Multiple Myeloma37 studies
- Metastatic Cancer33 studies
- Acute Myeloid Leukemia33 studies
- Lung Cancer32 studies
- Prostate Cancer32 studies
- Colorectal Cancer28 studies
- Chronic Lymphocytic Leukemia27 studies
- Ovarian Cancer27 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.